Matthew E. Korenberg

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
La Jolla, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Kathleen A. McGowan, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Matthew E. Korenberg

Form 4 holding President & COO

LIGAND PHARMACEUTICALS INC

Security class
Common Stock
Shares / value
50,777
Estimated value
$5,182,001
Report date
23 Sep 2024
Price
$102.05
Ownership
Direct
Form 4 holding CFO, Treasurer

PIERIS PHARMACEUTICALS, INC.

Security class
Non-Qualified Stock Option (right to buy)
Shares / value
123,559
Estimated value
Report date
05 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President & COO

LIGAND PHARMACEUTICALS INC

Security class
Employee Stock Option (right to buy)
Shares / value
58,544
Estimated value
Report date
27 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President & COO

LIGAND PHARMACEUTICALS INC

Security class
Employee Stock Option (right to buy)
Shares / value
42,436
Estimated value
Report date
23 Sep 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Qualigen Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
40,000
Estimated value
Report date
11 Jul 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CFO, Treasurer

PIERIS PHARMACEUTICALS, INC.

Security class
Incentive Stock Option (right to buy)
Shares / value
5,373
Estimated value
Report date
05 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Matthew E. Korenberg

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .